Nursing Assessment and Management of La Crosse Encephalitis in Pediatric Patients: Clinical Manifestations and Neurological Outcomes
Saudi Journal of Medicine and Public Health · 18.11.2026 · 3 (1) · 622-630
DOI: 10.64483/202631882 ↗Kurz gefasst
Fachartikel in der Zeitschrift Saudi Journal of Medicine and Public Health, online erschienen am 18.11.2026. Verfasst von Daifallah Dahwi Abdulrhman und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
La Crosse encephalitis is a mosquito-borne viral infection caused by La Crosse virus, an orthobunyavirus belonging to the California serogroup. The disease primarily affects children and represents an important cause of arboviral encephalitis in the United States. Although most infections remain asymptomatic or produce mild febrile illness, neuroinvasive disease can cause seizures, encephalopathy, cerebral edema, and long-term neurological complications.
Aim
This review examines the etiology, epidemiology, pathophysiology, histopathological characteristics, clinical manifestations, diagnostic evaluation, treatment, prognosis, and complications of La Crosse encephalitis, with emphasis on clinical assessment and nursing management.
Methods
A narrative review approach was used to examine the available clinical and scientific literature addressing La Crosse virus infection. Relevant evidence concerning viral transmission, disease mechanisms, clinical presentation, laboratory diagnosis, neuroimaging, supportive treatment, and short- and long-term outcomes was synthesized.
Results
La Crosse virus is transmitted primarily through infected Aedes mosquitoes, with vertical transmission contributing to viral persistence in mosquito populations. The incubation period ranges from 5 to 15 days. Symptomatic patients commonly develop fever, headache, vomiting, and lethargy, while severe cases may present with seizures, altered consciousness, and cerebral edema. Diagnosis primarily relies on virus-specific IgM antibody detection in serum or cerebrospinal fluid, supported by neutralizing antibody testing. No established specific antiviral treatment is available. Management focuses on supportive care, seizure control, fluid and electrolyte management, and respiratory support when required. Although mortality is relatively low, some survivors experience recurrent seizures, cognitive impairment, behavioral changes, and developmental difficulties.
Conclusion
Early recognition, appropriate diagnostic evaluation, and supportive management are essential to reduce complications and improve outcomes. Long-term neurological and developmental follow-up remains important, particularly in affected children.
Zitieren
APA
Abdulrhman, D. D., Alotaibi, N. M. M., Almutairi, R. A., Almutairi, F. M., Almutiri, S. K. R., Almotiri, A. S., Almutiri, A. O. A., Alhafi, M. A., Mutairi, H. M. M. A., & Almutayri, N. M. M. (2026). Nursing Assessment and Management of La Crosse Encephalitis in Pediatric Patients: Clinical Manifestations and Neurological Outcomes. Saudi Journal of Medicine and Public Health, 3(1), 622-630. https://doi.org/10.64483/202631882
Vancouver
Abdulrhman DD, Alotaibi NMM, Almutairi RA, Almutairi FM, Almutiri SKR, Almotiri AS, et al. Nursing Assessment and Management of La Crosse Encephalitis in Pediatric Patients: Clinical Manifestations and Neurological Outcomes. Saudi Journal of Medicine and Public Health. 2026;3(1):622-630. doi:10.64483/202631882
BibTeX
@article{Abdulrhman2026,
author = {Abdulrhman, Daifallah Dahwi and Alotaibi, Nouri Marzouq Mutlaq and Almutairi, Rahaf Abddulrahman and Almutairi, Faten Moeid and Almutiri, Seham Khalaf Rasheed and Almotiri, Ayda Saeed and Almutiri, Anbar Omar Amer and Alhafi, Maeetm Abdurhman and Mutairi, Huda Muhammad Metleaa Al and Almutayri, Nayafah Miedid Mishean},
title = {Nursing Assessment and Management of La Crosse Encephalitis in Pediatric Patients: Clinical Manifestations and Neurological Outcomes},
journal = {Saudi Journal of Medicine and Public Health},
year = {2026},
volume = {3},
number = {1},
pages = {622--630},
doi = {10.64483/202631882}
}
EUVIMED